• No results found

Amlodipine Besilate

Spectrophotometric and HPLC methods for simultaneous estimation of amlodipine besilate, losartan potassium and hydrochlorothiazide in tablets

Spectrophotometric and HPLC methods for simultaneous estimation of amlodipine besilate, losartan potassium and hydrochlorothiazide in tablets

... of amlodipine besilate, losartan potassium and hydrochlorothiazide in tablet dosage ...for amlodipine besilate, losartan potassium and hydrochlorothiazide, ...for amlodipine ...

5

 FORMULATION AND EVALUATION OF BILAYER TABLETS OF TWO INCOMPATIBLE DRUGS AMLODIPINE BESILATE AND LOSARTAN POTASSIUM

 FORMULATION AND EVALUATION OF BILAYER TABLETS OF TWO INCOMPATIBLE DRUGS AMLODIPINE BESILATE AND LOSARTAN POTASSIUM

... drugs Amlodipine besilate and Losartan potassium as an immediate release bi layer tablet and to evaluate its dissolution ...for amlodipine besilate ...for amlodipine besilate and ...

7

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS DETERMINATION OF ATORVASTATIN CALCIUM AND AMLODIPINE BESILATE IN TABLET DOSAGE FORM BY RP HPLC

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS DETERMINATION OF ATORVASTATIN CALCIUM AND AMLODIPINE BESILATE IN TABLET DOSAGE FORM BY RP HPLC

... then make up to the final volume. Further dilution was made by pipetting 10 ml of mother liquor into 50 ml volumetric flask and make up to the volume with mobile phase. The final conc. of Atorvastatin calcium and ...

7

Simultaneous estimation of amlodipine besilate and olmesartan medoxomil in pharmaceutical dosage form

Simultaneous estimation of amlodipine besilate and olmesartan medoxomil in pharmaceutical dosage form

... of amlodipine besilate and olmesartan medoxomil in tablet dosage ...for amlodipine besilate and olmesartan medoxomil with accuracy ...for amlodipine besilate and olmesartan ...

5

RP HPLC method development and validation for simultaneous estimation of Losartan Potassium, Amlodipine Besilate and Hydrochlorthiazide in tablet dosage form

RP HPLC method development and validation for simultaneous estimation of Losartan Potassium, Amlodipine Besilate and Hydrochlorthiazide in tablet dosage form

... A high-performance liquid chromatographic method has been developed for the simultaneous analysis of Losartan potassium, Amlodipine besilate and Hydrochlorthiazide in combined solid dosage form. The mobile ...

6

Method Development and Validation for the Analysis of Perindopril Erbumine and Amlodipine Besilate by Rp-Hplc in Pure and Pharmaceutical Dosage Form

Method Development and Validation for the Analysis of Perindopril Erbumine and Amlodipine Besilate by Rp-Hplc in Pure and Pharmaceutical Dosage Form

... To develop a simple, rapid and specific RP- HPLC method for the estimation of perindopril erbumine and amlodipine besilate in bulk and combined pharmaceutical dosage forms. To develop a simple, rapid, ...

11

Simultaneous determination of Amlodipine Besilate and Valsartan in pharmaceutical formulation using high performance liquid chromatography

Simultaneous determination of Amlodipine Besilate and Valsartan in pharmaceutical formulation using high performance liquid chromatography

... of amlodipine besilate and valsartan were accurately weighed and diluted with mobile phase to get the final concentration of 2-20 µg mL -1 for amlodipine besilate and 5-50 µg mL -1 for ...

6

Simultaneous UV Spectrophotometric Methods for Estimation of Amlodipine Besilate and Olmesartan Medoxomil in Tablet Dosage Form

Simultaneous UV Spectrophotometric Methods for Estimation of Amlodipine Besilate and Olmesartan Medoxomil in Tablet Dosage Form

... of Amlodipine besylate and Olmesartan medoxomil in combined tablet dosage form have been ...for Amlodipine besylate and olmesartan medoxomil were ...for Amlodipine besylate and olmesartan medoxomil ...

7

VALIDATED RP HPLC METHOD DEVELOPMENT FOR THE ESTIMATION OF LOSARTAN POTASSIUM IN MARKETED FORMULATION

VALIDATED RP HPLC METHOD DEVELOPMENT FOR THE ESTIMATION OF LOSARTAN POTASSIUM IN MARKETED FORMULATION

... for simultaneous estimation of amlodipine besilate, losartan potassium and hydrochlorothiazide. in tablets[r] ...

8

DESIGN AND IN VITRO EVALUATION OF BILAYER TABLET CONTAINING TWO INCOMPATIBLE ANTIHYPERTENSIVE DRUGS

DESIGN AND IN VITRO EVALUATION OF BILAYER TABLET CONTAINING TWO INCOMPATIBLE ANTIHYPERTENSIVE DRUGS

... drugs Amlodipine besilate and Losartan potassium as an immediate release bi layer tablet and to evaluate its dissolution ...for amlodipine besilate ...for Amlodipine and ...

11

Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference

Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference

... The enrolled patients were assigned sequentially accord- ing to a computer-generated randomization list to receive bepotastine besilate 1.5% or olopatadine hydrochloride 0.2% in a 1:1 ratio. Patients instilled ...

8

S amlodipine plus chlorthalidone vs  S amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial

S amlodipine plus chlorthalidone vs S amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial

... We have referred to two studies for sample size estima- tion. One study is regarding a combination therapy with chlorthalidone or valsartan as an add-on drug to diltia- zem [19], and the other one compared ...

8

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-b

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study

... This study was a multicenter, 8-week, randomized, double- blind, parallel group, Phase III clinical trial evaluating the efficacy and safety of S-amlodipine plus telmisartan fixed- dose combination (CKD-828) ...

10

Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting

Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting

... and/or amlodipine as a single therapy, or as a two-pill combination in the period prior the index date were ...and amlodipine as two pills in a combination treatment, or as single-pill treatment, was ...

8

Efficacy of fixed dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study

Efficacy of fixed dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study

... and amlodipine is among the newer antihypertensive combinations that have been extensively studied and shown to be effective in the management of hypertension ...of amlodipine/ losartan with ...

8

Comparative Evaluation of Efficacy and Safety of BepotastineBesilate versus Olopatadine and Ketorolac Combination in Patients with  Vernal Keratoconjunctivitis.

Comparative Evaluation of Efficacy and Safety of BepotastineBesilate versus Olopatadine and Ketorolac Combination in Patients with Vernal Keratoconjunctivitis.

... matches the pharmacological profile of the bepotastine besilate and the combination drug therapy of olopatadine with ketorolac. Moreover, as per the safety assessment, discontinuation due to adverse effect is none ...

6

In vitro drug-drug interaction study between Montelukast Sodium and Amlodipine Besylate at gastric and intestinal pH

In vitro drug-drug interaction study between Montelukast Sodium and Amlodipine Besylate at gastric and intestinal pH

... is used for treating high blood pressure, certain types of angina, and coronary heart failure. The drug works by slowing down the rate at which calcium moves to heart, blood vessel walls, allowing better blood flow. ...

7

A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk

A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk

... of amlodipine monotherapy. In the group treated with amlodipine 5 mg + ASA 100 mg, instead, there was a reduction of Hs-CRP ...to amlodipine alone ...with amlodipine 5 mg + ASA 100 mg compared ...

8

Development and Validation of Amlodipine Impurities in Amlodipine Tablets Using Design Space Computer Modeling

Development and Validation of Amlodipine Impurities in Amlodipine Tablets Using Design Space Computer Modeling

... A column with 150 mm length, 4.6 mm internal diameter and 3 µ particle sizes, C18 as stationary phase was used to separate all the impurities. Column temperature was maintained at 35˚C. All impurities were monitored at ...

10

Stability indicating HPLC method for the quantification of bepotastine besilate and its related substances*

Stability indicating HPLC method for the quantification of bepotastine besilate and its related substances*

... Chemical name: (+)-4-[[(S)-p-Chloro-alpha-2-pyridylbenzyl]oxy]-1-piperidine butyric acid monobenzenesulfonate. Recently, A rapid andsensitive method method for estimation of bepotastin in human plasma by LC-MS/MS method ...

9

Show all 354 documents...

Related subjects